Skip to main content
Erschienen in: Surgical Endoscopy 3/2012

01.03.2012

Risk factors for pancreatitis following transpapillary self-expandable metal stent placement

verfasst von: Kazumichi Kawakubo, Hiroyuki Isayama, Yousuke Nakai, Osamu Togawa, Naoki Sasahira, Hirofumi Kogure, Takashi Sasaki, Saburo Matsubara, Natsuyo Yamamoto, Kenji Hirano, Takeshi Tsujino, Nobuo Toda, Minoru Tada, Masao Omata, Kazuhiko Koike

Erschienen in: Surgical Endoscopy | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Pancreatitis is one of complications after self-expandable metal stent (SEMS) placement. The purpose of this study was to evaluate risk factors for pancreatitis after endoscopic SEMS placement for malignant biliary obstruction (MBO).

Methods

We retrospectively reviewed 370 consecutive patients who underwent initial transpapillary SEMS placement for biliary decompression. The characteristics of inserted SEMSs were classified according to axial and radial force.

Results

Pancreatitis following SEMS insertion was observed in 22 patients (6%). All of them were mild according to consensus criteria. Univariate analysis indicated that injections of contrast into the pancreatic duct (frequency of pancreatitis, 10.3%), the placement of an SEMS with high axial force (8.3%), and nonpancreatic cancer (16.1%) significantly contributed to the development of pancreatitis, whereas female gender, a younger age, a covered SEMS, and a SEMS with high radial force or without a biliary sphincterotomy did not. In a multivariate risk model, SEMSs with high axial force (odds ratio [OR], 3.69; p = 0.022) and nonpancreatic cancer (OR, 5.52; p < 0.001) were significant risk factors for pancreatitis.

Conclusions

SEMSs with high axial force and an etiology of MBO other than pancreatic cancer were strongly associated with a high incidence of pancreatitis following transpapillary SEMS placement in patients with distal MBO.
Literatur
1.
Zurück zum Zitat Knyrim K, Wagner HJ, Pausch J, Vakil N (1993) A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile-duct. Endoscopy 25:207–212PubMedCrossRef Knyrim K, Wagner HJ, Pausch J, Vakil N (1993) A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile-duct. Endoscopy 25:207–212PubMedCrossRef
2.
Zurück zum Zitat Davids PHP, Groen AK, Rauws EAJ, Tytgat GNJ, Huibregtse K (1992) Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340:1488–1492PubMedCrossRef Davids PHP, Groen AK, Rauws EAJ, Tytgat GNJ, Huibregtse K (1992) Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340:1488–1492PubMedCrossRef
3.
Zurück zum Zitat Isayama H, Yasuda I, Ryozawa S, Fujita N (2011) Results of a Japanese multicenter, randomized trial of endoscopic stenting for nonresectable pancreatic head cancer (JM-TEST): Covered Wallstent vs. double-layer stent. Dig Endosc 23:310–315PubMedCrossRef Isayama H, Yasuda I, Ryozawa S, Fujita N (2011) Results of a Japanese multicenter, randomized trial of endoscopic stenting for nonresectable pancreatic head cancer (JM-TEST): Covered Wallstent vs. double-layer stent. Dig Endosc 23:310–315PubMedCrossRef
4.
Zurück zum Zitat Kubota Y, Mukai H, Nakaizumi A, Yasuda K (2005) Covered Wallstent for palliation of malignant common bile duct stricture: prospective multicenter evaluation. Dig Endosc 17:218–223CrossRef Kubota Y, Mukai H, Nakaizumi A, Yasuda K (2005) Covered Wallstent for palliation of malignant common bile duct stricture: prospective multicenter evaluation. Dig Endosc 17:218–223CrossRef
5.
Zurück zum Zitat Telford JJ, Carr-Locke DL, Baron TH et al (2010) A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc 72:907–914PubMedCrossRef Telford JJ, Carr-Locke DL, Baron TH et al (2010) A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc 72:907–914PubMedCrossRef
6.
Zurück zum Zitat Kullman E, Frozanpor F, Soderlund C et al (2010) Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc 72:915–923PubMedCrossRef Kullman E, Frozanpor F, Soderlund C et al (2010) Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc 72:915–923PubMedCrossRef
7.
Zurück zum Zitat Cote GA, Kumar N, Ansstas M et al (2010) Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc 72:748–754PubMedCrossRef Cote GA, Kumar N, Ansstas M et al (2010) Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc 72:748–754PubMedCrossRef
8.
Zurück zum Zitat Kahaleh M, Tokar J, Conaway MR et al (2005) Efficacy and complications of covered Wallstents in malignant distal biliary obstruction. Gastrointest Endosc 61:528–533PubMedCrossRef Kahaleh M, Tokar J, Conaway MR et al (2005) Efficacy and complications of covered Wallstents in malignant distal biliary obstruction. Gastrointest Endosc 61:528–533PubMedCrossRef
9.
Zurück zum Zitat Isayama H, Komatsu Y, Tsujino T et al (2004) A prospective randomised study of “covered’’ versus “uncovered’’ diamond stents for the management of distal malignant biliary obstruction. Gut 53:729–734PubMedCrossRef Isayama H, Komatsu Y, Tsujino T et al (2004) A prospective randomised study of “covered’’ versus “uncovered’’ diamond stents for the management of distal malignant biliary obstruction. Gut 53:729–734PubMedCrossRef
10.
Zurück zum Zitat Cotton PB, Garrow DA, Gallagher J, Romagnuolo J (2009) Risk factors for complications after ERCP: a multivariate analysis of 11, 497 procedures over 12 years. Gastrointest Endosc 70:80–88PubMedCrossRef Cotton PB, Garrow DA, Gallagher J, Romagnuolo J (2009) Risk factors for complications after ERCP: a multivariate analysis of 11, 497 procedures over 12 years. Gastrointest Endosc 70:80–88PubMedCrossRef
11.
Zurück zum Zitat Freeman ML, Guda NM (2004) Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 59:845–864PubMedCrossRef Freeman ML, Guda NM (2004) Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 59:845–864PubMedCrossRef
12.
Zurück zum Zitat Tarnasky PR, Cunningham JT, Hawes RH et al (1997) Transpapillary stenting of proximal biliary strictures: does biliary sphincterotomy reduce the risk of postprocedure pancreatitis? Gastrointest Endosc 45:46–51PubMedCrossRef Tarnasky PR, Cunningham JT, Hawes RH et al (1997) Transpapillary stenting of proximal biliary strictures: does biliary sphincterotomy reduce the risk of postprocedure pancreatitis? Gastrointest Endosc 45:46–51PubMedCrossRef
13.
Zurück zum Zitat Isayama H, Nakai Y, Toyokawa Y et al (2009) Measurement of radial and axial forces of biliary self-expandable metallic stents. Gastrointest Endosc 70:37–44PubMedCrossRef Isayama H, Nakai Y, Toyokawa Y et al (2009) Measurement of radial and axial forces of biliary self-expandable metallic stents. Gastrointest Endosc 70:37–44PubMedCrossRef
14.
Zurück zum Zitat Cotton PB, Lehman G, Vennes J et al (1991) Endoscopic sphincterotomy complications and their management - an attempt at consensus. Gastrointest Endosc 37:383–393PubMedCrossRef Cotton PB, Lehman G, Vennes J et al (1991) Endoscopic sphincterotomy complications and their management - an attempt at consensus. Gastrointest Endosc 37:383–393PubMedCrossRef
15.
Zurück zum Zitat Artifon ELA, Sakai P, Ishioka S et al (2008) Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial. J Clin Gastroenterol 42:815–819PubMedCrossRef Artifon ELA, Sakai P, Ishioka S et al (2008) Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial. J Clin Gastroenterol 42:815–819PubMedCrossRef
16.
Zurück zum Zitat Yoon WJ, Lee JK, Lee KH et al (2006) A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc 63:996–1000PubMedCrossRef Yoon WJ, Lee JK, Lee KH et al (2006) A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc 63:996–1000PubMedCrossRef
17.
Zurück zum Zitat Isayama H, Kawabe T, Nakai Y, Komatsu Y, Omata M (2004) Covered metallic stents for management of distal malignant biliary obstruction. Dig Endosc 16:S104–S106CrossRef Isayama H, Kawabe T, Nakai Y, Komatsu Y, Omata M (2004) Covered metallic stents for management of distal malignant biliary obstruction. Dig Endosc 16:S104–S106CrossRef
18.
Zurück zum Zitat Nakai Y, Isayama H, Komatsu Y et al (2005) Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction. Gastrointest Endosc 62:742–748PubMedCrossRef Nakai Y, Isayama H, Komatsu Y et al (2005) Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction. Gastrointest Endosc 62:742–748PubMedCrossRef
19.
Zurück zum Zitat Cotton PB, Connor P, Rawls E, Romagnuolo J (2008) Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc 67:471–475PubMedCrossRef Cotton PB, Connor P, Rawls E, Romagnuolo J (2008) Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc 67:471–475PubMedCrossRef
20.
Zurück zum Zitat Freeman ML, Nelson DB, Sherman S et al (1996) Complications of endoscopic biliary sphincterotomy. N Engl J Med 335:909–918PubMedCrossRef Freeman ML, Nelson DB, Sherman S et al (1996) Complications of endoscopic biliary sphincterotomy. N Engl J Med 335:909–918PubMedCrossRef
21.
Zurück zum Zitat Wilcox CM, Phadnis M, Varadarajulu S (2010) Biliary stent placement is associated with post-ERCP pancreatitis. Gastrointest Endosc 72:546–550PubMedCrossRef Wilcox CM, Phadnis M, Varadarajulu S (2010) Biliary stent placement is associated with post-ERCP pancreatitis. Gastrointest Endosc 72:546–550PubMedCrossRef
22.
Zurück zum Zitat Loew BJ, Howell DA, Sanders MK et al (2009) Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc 70:445–453PubMedCrossRef Loew BJ, Howell DA, Sanders MK et al (2009) Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc 70:445–453PubMedCrossRef
23.
Zurück zum Zitat Weston BR, Ross WA, Liu J, Lee JH (2010) Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures: is there a difference? Gastrointest Endosc 72:1195–1200PubMedCrossRef Weston BR, Ross WA, Liu J, Lee JH (2010) Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures: is there a difference? Gastrointest Endosc 72:1195–1200PubMedCrossRef
24.
Zurück zum Zitat Nakai Y, Isayama H, Togawa O et al (2011) New method of covered wallstents for distal malignant biliary obstruction to reduce early stent-related complications based on characteristics. Dig Endosc 23:49–55PubMedCrossRef Nakai Y, Isayama H, Togawa O et al (2011) New method of covered wallstents for distal malignant biliary obstruction to reduce early stent-related complications based on characteristics. Dig Endosc 23:49–55PubMedCrossRef
25.
Zurück zum Zitat Simmons DT, Petersen BT, Gostout CJ, Levy MJ, Topazian MD, Baron TH (2008) Risk of pancreatitis following endoscopically placed large-bore plastic biliary stents with and without biliary sphincterotomy for management of postoperative bile leaks. Surg Endosc 22:1459–1463PubMedCrossRef Simmons DT, Petersen BT, Gostout CJ, Levy MJ, Topazian MD, Baron TH (2008) Risk of pancreatitis following endoscopically placed large-bore plastic biliary stents with and without biliary sphincterotomy for management of postoperative bile leaks. Surg Endosc 22:1459–1463PubMedCrossRef
26.
Zurück zum Zitat Banerjee N, Hilden K, Baron TH, Adler DG (2010) Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction. Dig Dis Sci 56:591–595PubMedCrossRef Banerjee N, Hilden K, Baron TH, Adler DG (2010) Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction. Dig Dis Sci 56:591–595PubMedCrossRef
Metadaten
Titel
Risk factors for pancreatitis following transpapillary self-expandable metal stent placement
verfasst von
Kazumichi Kawakubo
Hiroyuki Isayama
Yousuke Nakai
Osamu Togawa
Naoki Sasahira
Hirofumi Kogure
Takashi Sasaki
Saburo Matsubara
Natsuyo Yamamoto
Kenji Hirano
Takeshi Tsujino
Nobuo Toda
Minoru Tada
Masao Omata
Kazuhiko Koike
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 3/2012
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-011-1950-4

Weitere Artikel der Ausgabe 3/2012

Surgical Endoscopy 3/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.